Authors


Tino Otte

Latest:

Extractables and Leachables Testing for Inhaled Medicines

Follow guidelines for E&L studies of an orally inhaled and nasal drug product formulation in its delivery device.


Richard A. Lewis

Latest:

Stage 2 Process Validation: Regulatory Expectations and Approaches to Determine and Justify the Number of PPQ Batches

The authors summarize the current regulatory expectations regarding the number of PPQ batches required and provide potential approaches that can be used to determine and justify the number of PPQ batches.


Kathleen A. Estes

Latest:

Overcoming Concerns to Adopting Continuous Processes

Despite the benefits of continuous processing adoption has been slow, except for a few process areas.


Sanjay Sarma

Latest:

Working Smarter: Establishing an Effective Serialization Architecture

The author shares his opinion on the challenges presented by the Internet of Things and what companies need to consider when choosing suitable architectures to manage serialization data.


James C. Greenwood

Latest:

Drug Spending Not Driving Rising Health Care Costs

New reports indicate that drug prices are slowing compared to other healthcare costs.


Melanie Zerulla-Wernitz

Latest:

Analysis of Sub-Visible Particles

Novel analytical methods may help biologics manufacturers respond to stricter regulations on particulate matter.


Patheon

Latest:

Patheon OneSource™

Patheon OneSource™ helps small and emerging pharmaceutical companies lower risk and drive more predictable outcomes by integrating drug substance and drug product development decisions within a single CDMO.



Peter Kapferer

Latest:

Construction Approach of a Phosgenation Laboratory and GMP Plant at Valsynthese

The author describes the construction approach of a phosgene R&D laboratory and a medium-scale commercial phosgenation plant at Valsynthese.


Moheb M. Nasr

Latest:

FDA Perspectives: Understanding Challenges to Quality by Design

Directors from FDA's Center for Drug Evaluation and Research summarize findings in an FDA-commissioned report on QbD and propose actions the agency can take to encourage full-scale QbD implementation.


Andreas Stolle

Latest:

The Fine Chemicals Market

The increased trend of outsourcing coupled with a relatively strong economy has seen the fine chemicals market grow at a very high level when compared to historical data.




MilliporeSigma

Latest:

Enhancing API Solubility During API Processing and Formulation Development MilliporeSigma

Understanding the impact of API solubility on the performance of a given drug product and determining ways to enhance dissolution rates is critical to ensuring your product makes it to market, into the hands of patients and clinicians, is well absorbed and provides its intended therapeutic effect. Selecting the best formulation strategy to address challenges for each API, however, can be time-consuming, costly and complex.


ABITEC Corporation

Latest:

ABITEC Corporation

ABITEC is a global leader in the development and manufacture of specialty lipids and surfactants. Through our world-class technical, scientific, regulatory and manufacturing expertise, we deliver the highest quality solutions in solubilisation, emulsification, and lubrication. Our mission is to develop and manufacture functional lipids to meet and exceed the application demands of the Pharmaceutical, Nutritional, and Specialty Chemical industries.


Elizabeth Shen, PhD

Latest:

Coatings Sweeten Pharma Tablet Production

Materials and equipment innovations have advanced tablet coating from sugar to copolymers and simplified pharma production.


Tom Tice

Latest:

A 30-Year History of PLG Applications in Parenteral Controlled Drug Release

Poly(lactide-glycolide) has been used for drug-delivery applications because of its beneficial physicochemical properties, long safety record, and reliable commercial supply.


Matthew Moorcroft

Latest:

History Guides Future CMO Strategies

As pharma models changed during the past 40 years, contract manufacturing capacity and services evolved to meet demand.


Mike Tracey

Latest:

The Commitment Continues

Pharmaceutical Technology marks 40 years covering the bio/pharma industry.


James A. Koziol

Latest:

Analysis of Total and Transferrin-Bound Iron from Serum Samples

Incorporating structural constraints into pharmacokinetic studies of iron sucrose formulations.


Michael A. Grossman

Latest:

Analysis of Total and Transferrin-Bound Iron from Serum Samples

Incorporating structural constraints into pharmacokinetic studies of iron sucrose formulations.


Konstantin Konstantinov

Latest:

Determining Protein Oxidation Induced During Fill-Finish Operations

The effect of absorbed vapor-phase hydrogen peroxide on a lyophilized product Protein Z, was studied by spiking experiments with different amounts of hydrogen peroxide.


Orlando Lopez

Latest:

Maxims of Electronic Records Integrity

Managing and controlling e-records is vital for maintaining CGMP data integrity.


Agilent

Latest:

Determination of Eight Nitrosamine Impurities

This application note demonstrates that the Agilent 6475 triple quadrupole LC/MS system can confidently quantify nitrosamine impurities at the low concentration levels specified by regulatory requirements. This method can be used to quantify these impurities in different ARB drug products, with some changes in chromatographic conditions based on the elution pattern of the drug product.







Anthony Warchut

Latest:

Want Faster and Cheaper with Higher Quality? Get it Right the First Time

Weak or faulty quality systems can hurt a company at every stage of a product’s lifecycle.